Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0149 USD | +16.04% | +9.56% | -76.72% |
Financials (USD)
Sales 2022 | 16.84 | Sales 2023 | 18.22 | Capitalization | 1.28M |
---|---|---|---|---|---|
Net income 2022 | -76M | Net income 2023 | 53M | EV / Sales 2022 | 4,528,434 x |
Net Debt 2022 | 68.36M | Net Debt 2023 | 43.37M | EV / Sales 2023 | 2,451,077 x |
P/E ratio 2022 |
-0.05
x | P/E ratio 2023 |
1.2
x | Employees | 38 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Latest transcript on Evofem Biosciences, Inc.
1 day | +16.04% | ||
1 week | +9.56% | ||
Current month | -38.17% | ||
1 month | -6.88% | ||
3 months | -50.00% | ||
6 months | -82.47% | ||
Current year | -76.72% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 12-12-31 | |
Ivy Zhang
DFI | Director of Finance/CFO | 46 | 18-02-28 |
Amy Raskopf
IRC | Investor Relations Contact | - | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 12-12-31 | |
Kim Kamdar
BRD | Director/Board Member | 56 | 17-12-31 |
Colin Rutherford
BRD | Director/Board Member | 65 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.0149 | +16.04% | 740,620 |
24-04-23 | 0.0128 | -19.25% | 1,921,977 |
24-04-22 | 0.0159 | +3.25% | 157,974 |
24-04-19 | 0.0154 | +9.22% | 369,086 |
24-04-18 | 0.0141 | +3.68% | 182,360 |
Delayed Quote OTC Markets, April 24, 2024 at 03:58 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-76.72% | 804K | |
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- EVFM Stock